ArticleEpilepsia open2020

Efficacy and safety of perampanel monotherapy in patients with focal-onset seizures with newly diagnosed epilepsy or recurrence of epilepsy after a period of remission: The open-label Study 342 (FREEDOM Study).

Takamichi Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.